{
  "id": 105314,
  "name": "ABBVIE, INC.",
  "slug": "abbvie-inc",
  "state": "DC",
  "description": "Pharmaceutical researcher and manufacturer",
  "totalSpending": 1800000,
  "filings": 28,
  "yearlySpending": [
    {
      "year": 2018,
      "income": 240000
    },
    {
      "year": 2019,
      "income": 240000
    },
    {
      "year": 2020,
      "income": 240000
    },
    {
      "year": 2021,
      "income": 90000
    },
    {
      "year": 2022,
      "income": 120000
    },
    {
      "year": 2023,
      "income": 150000
    },
    {
      "year": 2024,
      "income": 80000
    },
    {
      "year": 2025,
      "income": 240000
    }
  ],
  "firms": [
    "BAKER & HOSTETLER LLP"
  ],
  "lobbyists": [
    "CHRIS JONES",
    "ADAM HIGGINS",
    "TYLER THOMPSON",
    "PETER ROSKAM"
  ],
  "issues": [
    "HCR",
    null,
    "TAX"
  ],
  "sampleDescriptions": [
    "Policy issues relating to federal healthcare programs\nHR 1892, the Bipartisan Budget Act\nHR 1625, the Consolidated Appropriations Act",
    "Regulatory and reimbursement policy issues related to federal healthcare programs, including Medicare and Medicaid.",
    "Regulatory and reimbursement policy issues related to federal healthcare programs, including Medicare.",
    "Multiple tax policies, including provisions of the Tax Cuts and Jobs Act.",
    "Multiple tax policies, including provisions of Public Law No. 115-97 and Public Law No. 119-21."
  ],
  "years": [
    2018,
    2019,
    2020,
    2021,
    2022,
    2023,
    2024,
    2025
  ],
  "growthRate": 0,
  "trajectory": "stable",
  "yearsActive": 8,
  "avgAnnualSpending": 175000,
  "peakYear": 2018,
  "lobbyistCount": 4,
  "firmCount": 1,
  "issueCount": 2
}